Skip to main content
Fig. 5 | BMC Pulmonary Medicine

Fig. 5

From: Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study

Fig. 5

Proportion of patients who achieved at least one week of Well-Controlled asthma during Phase II. Data pooled across all strata within a treatment. This analysis included Phase II treatment only (up to 40 weeks) and control was assessed at each individual week after Phase I. Phase I control status was based on an 8-week assessment period. FP fluticasone propionate, Ph I Phase I, SAL salmeterol, WC well controlled

Back to article page